255 related articles for article (PubMed ID: 3867125)
1. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
Marbet GA; Griffith MJ; Roberts HR
Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
[TBL] [Abstract][Full Text] [Related]
2. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
Marbet GA; Griffith MJ
Thromb Haemost; 1986 Feb; 55(1):78-85. PubMed ID: 3518133
[TBL] [Abstract][Full Text] [Related]
3. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
[TBL] [Abstract][Full Text] [Related]
6. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
8. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
9. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
11. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
Hauptmann J; Brüggener E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
[TBL] [Abstract][Full Text] [Related]
12. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
Mischke R; Fehr M; Nolte I
Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
[TBL] [Abstract][Full Text] [Related]
14. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.
Olrik Berthelsen L; Thuri Kristensen A; Wiinberg B; Tranholm M
Thromb Res; 2009 Sep; 124(4):490-7. PubMed ID: 19525002
[TBL] [Abstract][Full Text] [Related]
15. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
Tunali T; Yarat A; Bulut M; Emekli N
Br J Haematol; 2004 Jul; 126(2):226-30. PubMed ID: 15238144
[TBL] [Abstract][Full Text] [Related]
16. Disseminated intravascular coagulation following Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor.
Schaeffer RC; Briston C; Chilton SM; Carlson RW
J Lab Clin Med; 1986 Jun; 107(6):488-97. PubMed ID: 3086470
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
18. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
19. The effect of prophylactic heparinization on DIC arising from transitory circulatory arrest in dogs.
Takemoto Y; Tanabe J; Tanaka S; Fukuda A; Fujii C; Kohama A; Shibata S
Circ Shock; 1985; 15(2):131-9. PubMed ID: 3978765
[TBL] [Abstract][Full Text] [Related]
20. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]